# DEXMEDETOMIDINE in NORMAL VAGINAL DELIVERY

> **NCT05840328** · PHASE4 · UNKNOWN · sponsor: **Menoufia University** · enrollment: 60 (estimated)

## Conditions studied

- Painless Vainal Labour

## Interventions

- **DRUG:** Dexmedetomidine Injection [Precedex]
- **DRUG:** Bupivacaine Injection

## Key facts

- **NCT ID:** NCT05840328
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-05
- **Primary completion:** 2023-06-05
- **Final completion:** 2023-07-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05840328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05840328, "DEXMEDETOMIDINE in NORMAL VAGINAL DELIVERY". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05840328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*